SIG Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History

SIG Brokerage’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,500	Closed	-$4.31M	–	988
2025 Q4	$4.31M	Sell	9,500 -5,600	-37%	-$2.41M	0.13%	128
2025 Q3	$5.91M	Buy	15,100 +7,600	+101%	+$3.18M	0.17%	110
2025 Q2	$3.34M	Hold	7,500	–	–	0.09%	158
2025 Q1	$3.64M	Hold	7,500	–	–	0.18%	96
2024 Q4	$3.02M	Buy	+7,500	New	+$3.48M	0.16%	94

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SIG Brokerage's VRTX Position: Q1 2026 in Review

SIG Brokerage reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q1 2026, selling an estimated $1.52M and leaving 17,605 shares worth $7.86M. The position accounts for 0.21% of the portfolio, ranked #92.

SIG Brokerage first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.5M in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

SIG Brokerage held 17,605 shares of Vertex Pharmaceuticals worth $7.86M as of Q1 2026.
SIG Brokerage sold 3,259 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.52M.
Vertex Pharmaceuticals made up 0.21% of SIG Brokerage's portfolio in Q1 2026, its #92 holding.
SIG Brokerage first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
SIG Brokerage's Vertex Pharmaceuticals position peaked at $14.5M in Q2 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.